MARKET INTEL |
PRIME GRANT

Project - 60NANB22D168

OVERVIEW

Original Description
PURPOSE:THE PURPOSE OF THIS PROJECT IS TO USE MACHINE LEARNING AND OTHER ADVANCED COMPUTATIONAL METHODS TO ACCELERATE THE THERAPEUTIC DRUG DISCOVERY PROCESS.ACTIVITIES TO BE PERFORMED:THE RESEARCHERS WILL ACQUIRE AND IMPLEMENT A HIGH-PERFORMANCE DATA ANALYTIC AND COMPUTING INFRASTRUCTURE AT THE UNIVERSITY AT BUFFALO (UB). THEY WILL USE THIS INFRASTRUCTURE TO APPLY THE COMPUTATIONAL ANALYSIS OF NOVEL DRUG OPPORTUNITIES (CANDO) PLATFORM TO DISCOVER AND DESIGN THERAPEUTIC DRUG THERAPIES TO TREAT A VARIETY OF HIGH PRIORITY DISEASES.EXPECTED OUTCOMES:THE PROJECT EXPECTS TO RAPIDLY IDENTIFY NOVEL COMPOUNDS WITH THE POTENTIAL TO BE USED AS THERAPEUTICS. IN ADDITION, THIS FACILITY WILL IMPROVE RESEARCH, TRAINING, AND EDUCATION ACTIVITIES AT UB.INTENDED BENEFICIARIES:THIS IS TO ACQUIRE A HIGH-PERFORMANCE DATA ANALYTIC INFRASTRUCTURE TO SUPPORT A COMPUTATIONAL DRUG DISCOVERY PLATFORM. THIS WILL LEAD TO COMMERCIALIZATION OF NEW DRUGS FOR PATIENT USE BENEFITING THE US PHARMACEUTICAL INDUSTRY, PUBLIC, AND RESEARCHERS INTERESTED IN DRUG DISCOVERY METHODS.SUBRECIPIENT ACTIVITIES:THE RECIPIENT DOES NOT INTEND TO SUB AWARD FUNDS.
Assistance Type
Project Grant (B)
Place of Performance
Buffalo, New York 14228-2567 USA
Related Opportunity
None

STATUS

Period of Performance

11/1/22

Start Date

10/31/23

End Date
0% Complete

Funding Split

$1.0M

Federal Obligation

$0.0

Non-Federal Obligation

$1.0M

Total Obligated
100.0% Federal Funding
0.0% Non-Federal Funding

ACTIVITY TIMELINE

SUBGRANT AWARDS

TRANSACTION HISTORY

ADDITIONAL DETAIL

Award ID FAIN
60NANB22D168
SAI Number
60NANB22D168_0
Award ID URI
EXE
Awardee Classifications
Other
Awarding Office
1333ND DEPT OF COMMERCE NIST
Funding Office
1333ND DEPT OF COMMERCE NIST
Last Modified: 9/20/22